Working… Menu

Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids (PRIMROSE 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03070951
Recruitment Status : Completed
First Posted : March 6, 2017
Last Update Posted : March 5, 2021
Information provided by (Responsible Party):
ObsEva SA

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 16, 2019
Actual Study Completion Date : October 4, 2020
Certification/Extension First Submitted : January 29, 2021